IMC Chicago’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.2M Buy
760,100
+409,900
+117% +$19M 0.01% 819
2026
Q2
$14.9M Sell
350,200
-503,900
-59% -$27.4M ﹤0.01% 1265
2026
Q1
$53.6M Buy
854,100
+483,100
+130% +$38.6M 0.02% 485
2025
Q4
$35.4M Sell
371,000
-230,000
-38% -$22.5M 0.01% 607
2025
Q3
$58.7M Buy
601,000
+212,500
+55% +$22M 0.02% 415
2025
Q2
$41.7M Buy
388,500
+108,200
+39% +$10.9M 0.02% 443
2025
Q1
$28.3M Sell
280,300
-35,100
-11% -$3.53M 0.02% 467
2024
Q4
$28.2M Sell
315,400
-48,900
-13% -$4.3M 0.01% 493
2024
Q3
$30.5M Buy
364,300
+73,400
+25% +$5.79M 0.02% 424
2024
Q2
$22.4M Buy
290,900
+75,700
+35% +$5.54M 0.01% 496
2024
Q1
$14.7M Sell
215,200
-2,600
-1% -$167K 0.01% 566
2023
Q4
$12.6M Buy
217,800
+78,200
+56% +$4.17M 0.01% 587
2023
Q3
$7.37M Buy
139,600
+86,700
+164% +$4.55M 0.01% 639
2023
Q2
$2.86M Buy
52,900
+30,800
+139% +$1.61M ﹤0.01% 777
2023
Q1
$1.11M Buy
22,100
+9,100
+70% +$429K ﹤0.01% 1006
2022
Q4
$602K Buy
+13,000
New +$563K ﹤0.01% 1110
2021
Q1
– Sell
-17,600
Closed -$633K – 1047
2020
Q4
$633K Sell
17,600
-16,400
-48% -$591K ﹤0.01% 922
2020
Q3
$1.3M Buy
34,000
+10,400
+44% +$401K ﹤0.01% 676
2020
Q2
$829K Buy
23,600
+1,200
+5% +$43.2K ﹤0.01% 741
2020
Q1
$731K Buy
+22,400
New +$875K ﹤0.01% 689
2019
Q1
– Sell
-11,600
Closed -$410K – 657
2018
Q4
$410K Buy
+11,600
New +$421K ﹤0.01% 673

Other funds holding BSX

IMC Chicago's BSX Position: Q3 2026 in Review

IMC Chicago increased its Boston Scientific (BSX) stake by 97% in Q3 2026, buying an estimated $8.62M and bringing the position to 377,698 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1274.

IMC Chicago first reported a position in BSX in Q4 2018 and has held it in 11 quarters since. The position peaked at $32.7M in Q1 2026. 1,516 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • IMC Chicago held 377,698 shares of Boston Scientific worth $16.5M as of Q3 2026.
  • IMC Chicago bought 186,107 Boston Scientific shares in Q3 2026, an estimated $8.62M.
  • Boston Scientific made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #1274 holding.
  • IMC Chicago first reported a position in Boston Scientific in Q4 2018 and has held it in 11 quarters since.
  • IMC Chicago's Boston Scientific position peaked at $32.7M in Q1 2026.
  • 1,516 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.